Why is Chemo Pharma Lab falling/rising?

As of 13-Oct, Chemo Pharma Laboratories Ltd is experiencing a decline in its stock price, currently at 115.00, which reflects a decrease of 5.15 or 4.29%. The stock has been underperforming, having fallen for three consecutive days, resulting in a total decline of 14.72% during this period. Additionally, the stock's performance today has underperformed its sector by 1.51%. In terms of returns, the stock has shown a negative trend over the past week and month, with declines of 11.30% and 3.32%, respectively, although it has had a strong performance year-to-date and over the past year, with increases of 4.70% and 48.44%. There is no information available regarding positive or negative factors impacting the stock.
Broader Market Context: In comparison to the benchmark Sensex, which has gained 0.66% over the past week and 0.52% over the past month, Chemo Pharma's recent performance has been significantly weaker. The broader market appears to be stable, while Chemo Pharma's stock has faced challenges, including a notable drop in investor participation, with delivery volume plummeting by 95.02% against the five-day average. The overall sector, Miscellaneous, has also declined by 2.86%, contributing to the negative sentiment surrounding the stock.